Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

NIU researchers offer improved vector delivery system for ribozymes

Nov. 8, 1996

Scherer-Merck softgel development agreement

Nov. 8, 1996

CellPro to begin clinical trial of T-cell depletion system

Nov. 1, 1996

Lynx signs two agreements with BASF

Nov. 1, 1996

Strategy and outlook for HemaSure's blood pathogen inactivation system

Nov. 1, 1996

Andrx drug delivery technology receives patent coverage

Nov. 1, 1996

Varian, Stanford University and SRI collaborative agreement aimed at new cancer cures

Nov. 1, 1996

3-Dimensional Pharmaceutical's DirectedDiversity technology for drug discovery

Nov. 1, 1996

Xenova, Warner-Lambert sign drug discovery collaborative agreement

Nov. 1, 1996

NIH seeks licensees for method of detecting cardiac electrical activity

Oct. 25, 1996

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 24, 2026
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...